<SEC-DOCUMENT>0001516551-22-000033.txt : 20221003
<SEC-HEADER>0001516551-22-000033.hdr.sgml : 20221003
<ACCEPTANCE-DATETIME>20221003171453
ACCESSION NUMBER:		0001516551-22-000033
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20220929
ITEM INFORMATION:		Changes in Registrant's Certifying Accountant
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20221003
DATE AS OF CHANGE:		20221003

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Skye Bioscience, Inc.
		CENTRAL INDEX KEY:			0001516551
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				450692882
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-55136
		FILM NUMBER:		221288486

	BUSINESS ADDRESS:	
		STREET 1:		11250 EL CAMINO REAL, SUITE 100
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
		BUSINESS PHONE:		(858) 410-0266

	MAIL ADDRESS:	
		STREET 1:		11250 EL CAMINO REAL, SUITE 100
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Emerald Bioscience, Inc.
		DATE OF NAME CHANGE:	20190325

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Nemus Bioscience, Inc.
		DATE OF NAME CHANGE:	20141030

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LOAD GUARD LOGISTICS, INC.
		DATE OF NAME CHANGE:	20121107
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>skye-20220929.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:ddda5004-dcc4-4d93-9f42-4d99d6d0aeb8,g:cc7882d1-3379-4f16-86b2-09d595728a86,d:ad6ae96ce7df430e8a470cce60449290--><html xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>skye-20220929</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF80L2ZyYWc6MmYwYzI4MGJlOTM3NDg5OThkMmZjMDg5N2I5NzMwMGQvdGFibGU6YmZhNGRlZjRkMGY4NGQyMzhhMmVkYzJmMWRmYjFmNzYvdGFibGVyYW5nZTpiZmE0ZGVmNGQwZjg0ZDIzOGEyZWRjMmYxZGZiMWY3Nl8wLTEtMS0xLTEwNzQ5OQ_cfed0af1-4eb4-45a3-b364-ab2e86a2a5a5">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF80L2ZyYWc6MmYwYzI4MGJlOTM3NDg5OThkMmZjMDg5N2I5NzMwMGQvdGFibGU6YmZhNGRlZjRkMGY4NGQyMzhhMmVkYzJmMWRmYjFmNzYvdGFibGVyYW5nZTpiZmE0ZGVmNGQwZjg0ZDIzOGEyZWRjMmYxZGZiMWY3Nl8xLTEtMS0xLTEwNzQ5OQ_4326e528-5b74-4c61-893a-00b2a4bce40b">0001516551</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="skye-20220929.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516551</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-29</xbrli:startDate><xbrli:endDate>2022-09-29</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="iad6ae96ce7df430e8a470cce60449290_1"></div><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF8xL2ZyYWc6MjVkMTU5MDYwMmUzNDRlZTk2ZGViOTliYWIxYjVjYWQvdGV4dHJlZ2lvbjoyNWQxNTkwNjAyZTM0NGVlOTZkZWI5OWJhYjFiNWNhZF8xMTE2_8b618aa1-7340-4b34-b968-bc6db3389c8d">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;13 or 15(d)&#160;of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">the Securities Exchange Act of 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Date of report (Date of earliest event reported): <ix:nonNumeric contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF8xL2ZyYWc6MjVkMTU5MDYwMmUzNDRlZTk2ZGViOTliYWIxYjVjYWQvdGV4dHJlZ2lvbjoyNWQxNTkwNjAyZTM0NGVlOTZkZWI5OWJhYjFiNWNhZF8yMzA_5476a762-1fad-4167-a08f-dfdc3576da0a">September 29, 2022</ix:nonNumeric></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:28.993%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF8xL2ZyYWc6MjVkMTU5MDYwMmUzNDRlZTk2ZGViOTliYWIxYjVjYWQvdGV4dHJlZ2lvbjoyNWQxNTkwNjAyZTM0NGVlOTZkZWI5OWJhYjFiNWNhZF8xMTE0_e4140239-42db-4a00-bd53-3f81a48ca96e">SKYE BIOSCIENCE, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:28.993%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.018%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.018%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF8xL2ZyYWc6MjVkMTU5MDYwMmUzNDRlZTk2ZGViOTliYWIxYjVjYWQvdGFibGU6NmU4ZDU2NDk1NTU3NDc2YTk4OTE1YzUxYzljNGE1MmIvdGFibGVyYW5nZTo2ZThkNTY0OTU1NTc0NzZhOTg5MTVjNTFjOWM0YTUyYl8wLTAtMS0xLTEwNzQ5OQ_f79c8b3a-3cb9-42b5-bb68-33c9e6680817">Nevada</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF8xL2ZyYWc6MjVkMTU5MDYwMmUzNDRlZTk2ZGViOTliYWIxYjVjYWQvdGFibGU6NmU4ZDU2NDk1NTU3NDc2YTk4OTE1YzUxYzljNGE1MmIvdGFibGVyYW5nZTo2ZThkNTY0OTU1NTc0NzZhOTg5MTVjNTFjOWM0YTUyYl8wLTItMS0xLTEwNzQ5OQ_a109977f-8bff-4ba6-80ab-7b8ec23c766a">000-55136</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF8xL2ZyYWc6MjVkMTU5MDYwMmUzNDRlZTk2ZGViOTliYWIxYjVjYWQvdGFibGU6NmU4ZDU2NDk1NTU3NDc2YTk4OTE1YzUxYzljNGE1MmIvdGFibGVyYW5nZTo2ZThkNTY0OTU1NTc0NzZhOTg5MTVjNTFjOWM0YTUyYl8wLTQtMS0xLTEwNzQ5OQ_e0baac4e-ba7f-4fdb-87dd-4a52d7a37992">45-0692882</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(State or other jurisdiction of incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(I.R.S. Employer Identification Number)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF8xL2ZyYWc6MjVkMTU5MDYwMmUzNDRlZTk2ZGViOTliYWIxYjVjYWQvdGFibGU6MDIyYzBiNWJiNDhkNDNhYWFhYjMwNTNmNTk2NjY4NzMvdGFibGVyYW5nZTowMjJjMGI1YmI0OGQ0M2FhYWFiMzA1M2Y1OTY2Njg3M18wLTAtMS0xLTEwNzQ5OS90ZXh0cmVnaW9uOjQ3MGFlNTIyMGY5MTRhYTU4NzZjMGY1MzgwMmM5YTJlXzQ_d38e07ff-a5cd-468f-a4f3-8a542679f9fa">11250 El Camino Real</ix:nonNumeric>, <ix:nonNumeric contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF8xL2ZyYWc6MjVkMTU5MDYwMmUzNDRlZTk2ZGViOTliYWIxYjVjYWQvdGFibGU6MDIyYzBiNWJiNDhkNDNhYWFhYjMwNTNmNTk2NjY4NzMvdGFibGVyYW5nZTowMjJjMGI1YmI0OGQ0M2FhYWFiMzA1M2Y1OTY2Njg3M18wLTAtMS0xLTEwNzQ5OS90ZXh0cmVnaW9uOjQ3MGFlNTIyMGY5MTRhYTU4NzZjMGY1MzgwMmM5YTJlXzk_6008c927-d77e-485b-8ab8-65d592dc7d1c">Suite 100</ix:nonNumeric>, <ix:nonNumeric contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF8xL2ZyYWc6MjVkMTU5MDYwMmUzNDRlZTk2ZGViOTliYWIxYjVjYWQvdGFibGU6MDIyYzBiNWJiNDhkNDNhYWFhYjMwNTNmNTk2NjY4NzMvdGFibGVyYW5nZTowMjJjMGI1YmI0OGQ0M2FhYWFiMzA1M2Y1OTY2Njg3M18wLTAtMS0xLTEwNzQ5OS90ZXh0cmVnaW9uOjQ3MGFlNTIyMGY5MTRhYTU4NzZjMGY1MzgwMmM5YTJlXzEz_94f084d5-7e47-43fe-b52f-11f34d0110e9">San Diego</ix:nonNumeric>, <ix:nonNumeric contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF8xL2ZyYWc6MjVkMTU5MDYwMmUzNDRlZTk2ZGViOTliYWIxYjVjYWQvdGFibGU6MDIyYzBiNWJiNDhkNDNhYWFhYjMwNTNmNTk2NjY4NzMvdGFibGVyYW5nZTowMjJjMGI1YmI0OGQ0M2FhYWFiMzA1M2Y1OTY2Njg3M18wLTAtMS0xLTEwNzQ5OS90ZXh0cmVnaW9uOjQ3MGFlNTIyMGY5MTRhYTU4NzZjMGY1MzgwMmM5YTJlXzE3_7daac0ba-c273-403f-85e6-91107bfe8f99">CA</ix:nonNumeric> <ix:nonNumeric contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF8xL2ZyYWc6MjVkMTU5MDYwMmUzNDRlZTk2ZGViOTliYWIxYjVjYWQvdGFibGU6MDIyYzBiNWJiNDhkNDNhYWFhYjMwNTNmNTk2NjY4NzMvdGFibGVyYW5nZTowMjJjMGI1YmI0OGQ0M2FhYWFiMzA1M2Y1OTY2Njg3M18wLTAtMS0xLTEwNzQ5OS90ZXh0cmVnaW9uOjQ3MGFlNTIyMGY5MTRhYTU4NzZjMGY1MzgwMmM5YTJlXzIw_77e80a15-09da-4d27-ac6c-e7a5ec6cc859">92130</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(Address of principal executive offices)</span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">(<ix:nonNumeric contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF8xL2ZyYWc6MjVkMTU5MDYwMmUzNDRlZTk2ZGViOTliYWIxYjVjYWQvdGFibGU6NDM2YjIxNTIyMGE1NDcxZDhmNmFmOGNjYjQxYWU1ZTgvdGFibGVyYW5nZTo0MzZiMjE1MjIwYTU0NzFkOGY2YWY4Y2NiNDFhZTVlOF8wLTAtMS0xLTEwNzQ5OS90ZXh0cmVnaW9uOmJlYzY0OTdiYzM2ODRiYTdiMmE1MTE5NzRlZGQzNmM0XzU_ecfe7384-4b53-4971-a3c6-0d210741c93d">858</ix:nonNumeric>) <ix:nonNumeric contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF8xL2ZyYWc6MjVkMTU5MDYwMmUzNDRlZTk2ZGViOTliYWIxYjVjYWQvdGFibGU6NDM2YjIxNTIyMGE1NDcxZDhmNmFmOGNjYjQxYWU1ZTgvdGFibGVyYW5nZTo0MzZiMjE1MjIwYTU0NzFkOGY2YWY4Y2NiNDFhZTVlOF8wLTAtMS0xLTEwNzQ5OS90ZXh0cmVnaW9uOmJlYzY0OTdiYzM2ODRiYTdiMmE1MTE5NzRlZGQzNmM0Xzk_0f3fd77b-e3ce-4888-b84f-576a5f62e203">410-0266</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">_________________________</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF8xL2ZyYWc6MjVkMTU5MDYwMmUzNDRlZTk2ZGViOTliYWIxYjVjYWQvdGFibGU6MWFiMDNkZTM1ZWNhNDU4ZWI2YjIyNzA5OTViZGNmZGUvdGFibGVyYW5nZToxYWIwM2RlMzVlY2E0NThlYjZiMjI3MDk5NWJkY2ZkZV8wLTAtMS0xLTEwNzQ5OQ_8028f542-2ebc-4c2c-ac56-497bacb67dd5">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF8xL2ZyYWc6MjVkMTU5MDYwMmUzNDRlZTk2ZGViOTliYWIxYjVjYWQvdGFibGU6MWFiMDNkZTM1ZWNhNDU4ZWI2YjIyNzA5OTViZGNmZGUvdGFibGVyYW5nZToxYWIwM2RlMzVlY2E0NThlYjZiMjI3MDk5NWJkY2ZkZV8xLTAtMS0xLTEwNzQ5OQ_f660bb41-4da9-44d4-98ef-428940ae00a6">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF8xL2ZyYWc6MjVkMTU5MDYwMmUzNDRlZTk2ZGViOTliYWIxYjVjYWQvdGFibGU6MWFiMDNkZTM1ZWNhNDU4ZWI2YjIyNzA5OTViZGNmZGUvdGFibGVyYW5nZToxYWIwM2RlMzVlY2E0NThlYjZiMjI3MDk5NWJkY2ZkZV8yLTAtMS0xLTEwNzQ5OQ_8f62ae68-12e1-41d1-a707-b77890a69ecd">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF8xL2ZyYWc6MjVkMTU5MDYwMmUzNDRlZTk2ZGViOTliYWIxYjVjYWQvdGFibGU6MWFiMDNkZTM1ZWNhNDU4ZWI2YjIyNzA5OTViZGNmZGUvdGFibGVyYW5nZToxYWIwM2RlMzVlY2E0NThlYjZiMjI3MDk5NWJkY2ZkZV8zLTAtMS0xLTEwNzQ5OQ_cb83e66b-72f6-44b0-a15e-a35347420f11">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="padding-left:288pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF8xL2ZyYWc6MjVkMTU5MDYwMmUzNDRlZTk2ZGViOTliYWIxYjVjYWQvdGV4dHJlZ2lvbjoyNWQxNTkwNjAyZTM0NGVlOTZkZWI5OWJhYjFiNWNhZF8xMTE1_3a98ad2c-5cb8-44ae-8c2c-7c28b1a2de52">&#9744;</ix:nonNumeric></span></div><div style="padding-left:288pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.826%"><tr><td style="width:1.0%"></td><td style="width:31.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.772%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Title of each class</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Trading</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Symbol(s)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Name of each exchange</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">on which registered</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">N/A</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">N/A</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">N/A</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="iad6ae96ce7df430e8a470cce60449290_7"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="-sec-extract:summary;margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 4.01 Changes in Registrant's Certifying Accountant</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Based on information provided by Skye Bioscience, Inc.'s (the Company" or "Skye") independent registered public accounting firm, Friedman LLP, effective September 1, 2022, Friedman LLP ("Friedman") combined with Marcum LLP and continued to operate as an independent registered public accounting firm.</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Friedman continued to serve as the Company&#8217;s independent registered public accounting firm through September 29, 2022. On September 29, 2022, the Audit Committee of the Company approved the dismissal of Friedman LLP and the engagement of Marcum LLP to serve as the independent registered public accounting firm of the Company for the year ending December 31, 2022. The services previously provided by Friedman LLP will now be provided by Marcum LLP. </span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Friedman has not provided any reports on the Company&#8217;s consolidated financial statements for either of the past two years.</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the fiscal years ended December 31, 2021 and December 31, 2020, and the subsequent interim period through September 29, 2022, there were: (i) no disagreements within the meaning of Item 304(a)(1)(iv) of Regulation S-K between Skye and Friedman on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which, if not resolved to Friedman's, would have caused Friedman to make reference thereto Friedman&#8217;s reports; and (ii) no &#8220;reportable events&#8221; within the meaning of Item 304(a)(1)(v) of Regulation S-K.</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Skye provided Friedman with a copy of the foregoing disclosures and requested that Friedman furnish a letter addressed to the SEC stating whether or not it agrees with the foregoing disclosures. A copy of Friedman's letter, dated September 29, 2022, is filed as Exhibit 16.1 hereto.</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the fiscal years ended December 31, 2021 and December 31, 2020, and the subsequent interim period through September 29, 2022, the date of this Current Report, neither Skye nor anyone on its behalf has consulted with Marcum LLP regarding: (i) the application of accounting principles to a specific transaction, either completed or proposed, or the type of audit opinion that might be rendered on Skye&#8217;s financial statements, and neither a written report nor oral advice was provided to Skye that Marcum LLP concluded was an important factor considered by Skye in reaching a decision as to any accounting, auditing, or financial reporting issue&#894; (ii) any matter that was the subject of a disagreement within the meaning of Item 304(a)(1)(iv) of Regulation S-K&#894; or (iii) any &#8220;reportable event&#8221; within the meaning of Item 304(a)(1)(v) of Regulation S-K.</span></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 5.07 Submission of Matters to a Vote of Security Holders.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On September 30, 2022, the Company held its Special Meeting of Stockholders (&#8220;SKYE Meeting&#8221;). The SKYE Meeting was held virtually to vote on five proposals, each of which is described in more detail in the definitive proxy statement filed with the U.S. Securities and Exchange Commission on August 31, 2022 (the &#8220;Proxy Statement&#8221;). Only stockholders of record as of the close of business on August 29, 2022 (the &#8220;Record Date&#8221;) were entitled to vote at the SKYE Meeting. As of the Record Date, 495,925,112 shares of the Company&#8217;s common stock (&#8220;Common Stock&#8221;) were issued, outstanding and entitled to vote, of which 368,396,357 shares were represented, in person or by proxy, and constituted a quorum for purposes of the SKYE Meeting. The results of the stockholder vote on each proposal brought before the meeting were as follows: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Proposal 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The proposal to adopt the Arrangement Agreement, dated as of May 11, 2022, as amended on June 14, 2022 and July 15, 2022 (the &#8220;Arrangement Agreement&#8221;) between Skye and Emerald Health Therapeutics, Inc. (&#8220;EHT&#8221;), and to approve the transactions contemplated thereby, including the proposed arrangement (the &#8220;Arrangement&#8221;) involving, among other things, the acquisition by Skye of all of the outstanding EHT Shares (the &#8220;Arrangement Proposal&#8221;), was approved based upon the following votes:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Votes For*</span></td><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Votes Against*</span></td><td colspan="3" style="border-left:0.5pt solid #000;border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Abstentions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">162,369,593</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5,025,797</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-left:0.5pt solid #000;border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">111,431,876</span></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">*Excluding shares held or voted by (a) Emerald Health Sciences, Inc. or its affiliates, (b) directors or officers of EHT or Skye and (c) any immediate family members (as defined in Item 404 of Regulation S-K) of any of the officers or directors of EHT or Skye. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Proposal 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> The proposal to establish the Company&#8217;s 2022 Employee Stock Purchase Plan (the &#8220;ESPP Proposal&#8221;) was approved based upon the following votes: </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Votes For</span></td><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Votes Against</span></td><td colspan="3" style="border-left:0.5pt solid #000;border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Abstentions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">262,280,619</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">11,578,590</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-left:0.5pt solid #000;border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6,968,057</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Proposal 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The proposal to adopt and approve Skye&#8217;s Amended and Restated 2014 Omnibus Incentive Plan (the (the &#8220;Incentive Plan Proposal&#8221;), was approved based upon the following votes:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Votes For</span></td><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Votes Against</span></td><td colspan="3" style="border-left:0.5pt solid #000;border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Abstentions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">262,328,417</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">15,767,892</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-left:0.5pt solid #000;border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2,730,957</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Proposal 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The proposal ratify the appointment of Friedman LLP (combined with Marcum LLP effective September 1, 2022) as SKYE&#8217;s independent registered public accounting firm for the fiscal year ending December 31, 2022 (the &#8220;Independent Registered Public Accountants Proposal&#8221;), was approved based on the following votes: </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Votes For</span></td><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Votes Against</span></td><td colspan="3" style="border-left:0.5pt solid #000;border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Abstentions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">363,687,574</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3,938,519</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-left:0.5pt solid #000;border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">770,264</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Proposal 5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> The proposal to adjourn the SKYE Meeting, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes to approve the Arrangement Proposal, the Incentive Plan Proposal, the ESPP Proposal or the Independent Registered Public Accountants Proposal (the &#8220;Adjournment Proposal&#8221;), was approved based on the following votes: </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Votes For</span></td><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Votes Against</span></td><td colspan="3" style="border-left:0.5pt solid #000;border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Abstentions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">352,354,352</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">13,308,984</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-left:0.5pt solid #000;border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2,733,021</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 7.01 Regulation FD Disclosure</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On September 30, 2022, Skye issued a press release announcing the results of the SKYE Meeting. A copy of the press release is attached as Exhibit 99.1 to this current report on Form 8-K and is incorporated herein by reference.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In accordance with General Instruction B.2. of the Current Report on Form 8-K, the information set forth in Item 7.01 of this Current Report on Form 8-K and in the attached Exhibit 99.1 is deemed to be &#8220;furnished&#8221; and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall such information or Exhibit be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.</span></div><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01 Financial Statements and Exhibits.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Exhibits</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.121%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.148%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.331%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="skyeletteroffriedmanllptos.htm">Letter of Friedman, LLP to the Securities and Exchange Commission, dated September 29, 2022</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="skye_093022xvotingresultsp.htm">Press Release</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cover Page Interactive Data File (embedded within the inline XBRL document)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">*Filed herewith</span></div><div style="padding-left:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.090%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="iad6ae96ce7df430e8a470cce60449290_10"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.941%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.859%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;SKYE BIOSCIENCE, INC.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated:  October 3, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">/s/&#160; Punit Dhillon</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name: Punit Dhillon</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title: Chief Executive Officer</span></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-16.1
<SEQUENCE>2
<FILENAME>skyeletteroffriedmanllptos.htm
<DESCRIPTION>EX-16.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ie304cf1edcc045bbb9dd77140db6aa8a_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">September 29, 2022</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Securities and Exchange Commission</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100 F Street N.E.</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Washington, D.C. 20549</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Commissioners&#58;</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">We have read Item 4.01 of Skye Bioscience, Inc.&#8217;s Form 8-K dated September 29, 2022, and we agree with the statements set forth in Item 4.01, insofar as they relate to our firm. We have no basis to agree or disagree with other statements made by the registrant contained in Item 4.01.&#160;</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Very truly yours,</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">&#47;s&#47; Friedman LLP</font></div><div style="margin-bottom:0.05pt;margin-top:0.05pt"><font><br></font></div><div style="margin-bottom:0.05pt;margin-top:0.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Friedman LLP</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">East Hanover, New Jersey</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>skye_093022xvotingresultsp.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i7f539e42fff94157813b455d6218617a_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:112%">Skye Bioscience Stockholders Vote in Favor of Arrangement Agreement with Emerald Health Therapeutics, Inc.</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Additional capital from Arrangement Agreement expected to fund Skye&#8217;s Phase 1 and 2 clinical studies of proprietary synthetic cannabinoid-derivative therapeutic targeting glaucoma </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">San Diego, California, September 30, 2022 -- Skye Bioscience, Inc. (OTCQB&#58; SKYE) (&#8220;Skye&#8221; or the &#8220;Company&#8221;), a pharmaceutical company developing proprietary, synthetic cannabinoid derivatives to treat glaucoma and other diseases with significant unmet needs, reports that its stockholders voted in favor of all proposals presented at its special meeting held today, including the proposal to approve the proposed acquisition (the &#8220;Arrangement&#8221;) of Emerald Health Therapeutics, Inc. (the &#8220;EHT&#8221;) by Skye. A total of 74% of shares outstanding were represented in person or by proxy at the special meeting.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Excluding the votes of (a) Emerald Health Sciences, Inc. or its affiliates, (b) directors or officers of EHT or Skye and (c) any immediate family members (as defined in Item 404 of Regulation S-K) of any of the officers or directors of EHT or Skye, the proposal to approve the Arrangement with EHT was approved by 97% of votes cast by stockholders for that proposal. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Stockholders also voted in favor of establishing the Company&#8217;s 2022 Employee Stock Purchase Plan, adopting and approving Skye&#8217;s Amended and Restated 2014 Omnibus Incentive Plan, and ratifying the appointment of Friedman LLP as SKYE&#8217;s independent registered public accounting firm for the fiscal year ending December 31, 2022.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Shareholders of EHT voted in favor of the Arrangement with Skye on August 19, 2022 and the Supreme Court of British Columbia issued a final order approving the Arrangement on August 25, 2022. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Skye and EHT continue to work diligently towards closing the Arrangement and plan to proceed with the closing as soon as practicable following the satisfaction of all remaining closing conditions, including obtaining conditional listing approval from the Canadian Securities Exchange.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Update provided by Skye CEO Punit Dhillon following Skye&#8217;s shareholder meeting</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Punit Dhillon delivered the following remarks to shareholders immediately following the special meeting&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">I want to thank Skye&#8217;s stockholders for their broad voting participation in this special meeting and for their resounding vote in favor of the resolution regarding the Arrangement Agreement with EHT.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Your support of the merger with EHT will provide us with additional financial resources that we expect to extend our operating runway to fund the Phase 1 that we are starting imminently and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">the Phase 2 study for which we are preparing our Investigational New Drug application to submit to the FDA by year end and planning to start in 2023.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">I will again acknowledge and thank the EHT shareholders for their vote in favor of this transaction via their special meeting held on August 19th and which was approved by the British Columbia Supreme Court on August 25th.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">We look forward to welcoming Emerald Health Therapeutics shareholders as new Skye stockholders as we continue on our path to develop our cannabinoid derivative drug candidates for important diseases with unmet needs.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Today is an important day, with both shareholder groups now aligned. So what comes next&#63;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Skye&#8217;s agreement with Emerald Health Therapeutics called for the deal to be closed prior to October 15th. One key condition of closing is that Skye&#8217;s shares be listed to trade in Canada. We submitted our listing application to the Canadian Securities Exchange in late August and are in the process of satisfying their information requests. We have not set a closing date since there is uncertainty around the timing of their conditional approval. We will keep you updated.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Most exciting is that we are near to starting the company&#8217;s first-ever clinical study. We have met all of the regulatory requirements to start our Phase 1 trial for SBI-100 in Australia. Last week we announced that we had completed the production stage of our overall manufacturing process. We have just one final manufacturing step to complete, and that is quality and analytical testing to meet necessary standards. With receipt of that, we expect final drug product to be released and available for clinical use in October.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">With our planned site visit to train clinical site staff and investigators in the second week of October, we expect to dose our first clinical trial subjects in November. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">We are on the verge of turning the page to a whole new chapter of Skye&#8217;s advancement and our team is well-prepared and enthusiastic to take these next steps and is committed to make its best effort to implement a plan that can add value to the company.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:112%">About Skye Bioscience </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Skye Bioscience is a pharmaceutical company unlocking the potential of cannabinoids through the development of its proprietary cannabinoid derivatives to treat diseases with significant unmet needs. The Company&#8217;s lead program, SBI-100 OE, is focused on developing a treatment for glaucoma, the world&#8217;s leading cause of irreversible blindness. For more information, please visit&#58; </font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">www.skyebioscience.com</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:112%">CONTACT</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Investor Relations  Email&#58;&#8239;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">ir&#64;skyebioscience.com</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8239;&#8239;  Phone&#58; (858) 410-0266 </font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:112%">FORWARD LOOKING STATEMENTS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  This letter contains forward-looking statements, including statements regarding our product development, business strategy, the timing of clinical trials, and commercialization of cannabinoid-derived therapeutics. Such statements and other statements in this press release that are not descriptions of historical facts are forward-looking statements that are based on management&#8217;s current expectations and assumptions and are subject to risks and uncertainties. If such risks or uncertainties materialize or such assumptions prove incorrect, our business, operating results, financial condition, and stock price could be materially negatively affected. In some cases, forward-looking statements can be identified by terminology including &#8220;anticipated,&#8221; &#8220;plans,&#8221; &#8220;goal,&#8221; &#8220;focus,&#8221; &#8220;aims,&#8221; &#8220;intends,&#8221; &#8220;believes,&#8221; &#8220;can,&#8221; &#8220;could,&#8221; &#8220;challenge,&#8221; &#8220;predictable,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;may&#8221; or the negative of these terms or other comparable terminology. We operate in a rapidly changing environment, and new risks emerge from time to time. As a result, it is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements the Company may make. Risks and uncertainties that may cause actual results to differ materially include, among others, our capital resources, uncertainty regarding the results of future testing and development efforts and other risks that are described in the Risk Factors section of Skye&#8217;s most recent annual or quarterly report filed with the Securities and Exchange Commission. Except as expressly required by law, Skye disclaims any intent or obligation to update these forward-looking statements. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>skye-20220929.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:ddda5004-dcc4-4d93-9f42-4d99d6d0aeb8,g:cc7882d1-3379-4f16-86b2-09d595728a86-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:skye="http://skyebioscience.com/20220929" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://skyebioscience.com/20220929">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="skye-20220929_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="skye-20220929_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://skyebioscience.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>skye-20220929_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:ddda5004-dcc4-4d93-9f42-4d99d6d0aeb8,g:cc7882d1-3379-4f16-86b2-09d595728a86-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_PreCommencementTenderOffer_adef90ab-cd54-4b86-b59b-522f088a7217_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_300c5ab8-0a52-4ea5-a110-9973d0aed7e2_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_8f9619ac-ca99-4a7b-bba7-80f60a0bb630_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_99987b19-c015-4234-a12e-89a118b79cbe_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_b79b7075-9ab2-4583-8e36-34819b253de6_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_bfa0595e-ec95-4f6c-ac9e-11ccea00bee1_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_6c204da9-dc15-4d36-b8ca-d00a6eb01e15_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_425c4961-ddd7-4ae8-bb5a-b0541d0bfb8f_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_3e579557-9350-4732-a232-6144777c4028_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_bd62e4fe-7092-4c38-a375-733d2b7df2d9_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_ebfebdb1-c33c-4141-8f17-345322ea9fa7_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_0c78a16f-2b8e-4aec-a178-97d64246c7bf_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_29b85566-772c-43c3-b694-eea788f54d4c_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_e2e4c0ec-0099-4a05-96eb-0ca7ef6001fa_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_a07af90f-086a-415e-8e6c-bedbb8c85600_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_31a862db-eacd-4e7a-baf0-b2ed446785ff_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_afdea108-44b0-4fe2-af8d-c4e7f6c0a366_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_15e94dbd-f236-405c-89b3-fe86e1ca335f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_08351d9d-98a0-4c2a-965e-7e9605a8049c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_abf1658a-6de0-4011-92fa-67ca291115ce_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>skye-20220929_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:ddda5004-dcc4-4d93-9f42-4d99d6d0aeb8,g:cc7882d1-3379-4f16-86b2-09d595728a86-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://skyebioscience.com/role/CoverPage" xlink:type="simple" xlink:href="skye-20220929.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://skyebioscience.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_436c0dae-9ddd-46ae-bc6c-b6f8caae84a5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_b4cb6e23-aa8e-4566-b9f7-09d448296459" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_436c0dae-9ddd-46ae-bc6c-b6f8caae84a5" xlink:to="loc_dei_DocumentType_b4cb6e23-aa8e-4566-b9f7-09d448296459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_055af3a8-8df3-49ed-9bdf-3a9d7ccf31c5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_436c0dae-9ddd-46ae-bc6c-b6f8caae84a5" xlink:to="loc_dei_DocumentPeriodEndDate_055af3a8-8df3-49ed-9bdf-3a9d7ccf31c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_5e696f27-38c9-4e38-b156-111001a0d261" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_436c0dae-9ddd-46ae-bc6c-b6f8caae84a5" xlink:to="loc_dei_EntityRegistrantName_5e696f27-38c9-4e38-b156-111001a0d261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_ebd47da3-d489-4061-89b1-62a9df89ed3f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_436c0dae-9ddd-46ae-bc6c-b6f8caae84a5" xlink:to="loc_dei_EntityIncorporationStateCountryCode_ebd47da3-d489-4061-89b1-62a9df89ed3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_b1039840-5e8d-4577-b633-a3cd0408aa94" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_436c0dae-9ddd-46ae-bc6c-b6f8caae84a5" xlink:to="loc_dei_EntityFileNumber_b1039840-5e8d-4577-b633-a3cd0408aa94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_8ae8efef-f6ca-4bbe-9220-ed7dab89eaa7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_436c0dae-9ddd-46ae-bc6c-b6f8caae84a5" xlink:to="loc_dei_EntityTaxIdentificationNumber_8ae8efef-f6ca-4bbe-9220-ed7dab89eaa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_04df6f4f-b223-486c-9ef3-2c780b7444e2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_436c0dae-9ddd-46ae-bc6c-b6f8caae84a5" xlink:to="loc_dei_EntityAddressAddressLine1_04df6f4f-b223-486c-9ef3-2c780b7444e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_f36f77e3-4b60-4738-9d76-b3168886a2f4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_436c0dae-9ddd-46ae-bc6c-b6f8caae84a5" xlink:to="loc_dei_EntityAddressAddressLine2_f36f77e3-4b60-4738-9d76-b3168886a2f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_dd63d7b0-5fa5-4dce-a7aa-db5e862c13b7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_436c0dae-9ddd-46ae-bc6c-b6f8caae84a5" xlink:to="loc_dei_EntityAddressCityOrTown_dd63d7b0-5fa5-4dce-a7aa-db5e862c13b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_6d08a4fe-adf5-4309-a23d-657dee8fd5cf" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_436c0dae-9ddd-46ae-bc6c-b6f8caae84a5" xlink:to="loc_dei_EntityAddressStateOrProvince_6d08a4fe-adf5-4309-a23d-657dee8fd5cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_09bef0ba-3a47-483c-ba69-9d217860e4c2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_436c0dae-9ddd-46ae-bc6c-b6f8caae84a5" xlink:to="loc_dei_EntityAddressPostalZipCode_09bef0ba-3a47-483c-ba69-9d217860e4c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_e07a38a1-13fa-4fad-bf6d-c506c95f1f02" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_436c0dae-9ddd-46ae-bc6c-b6f8caae84a5" xlink:to="loc_dei_CityAreaCode_e07a38a1-13fa-4fad-bf6d-c506c95f1f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_472728a3-4b2c-447b-941b-6ce16e297136" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_436c0dae-9ddd-46ae-bc6c-b6f8caae84a5" xlink:to="loc_dei_LocalPhoneNumber_472728a3-4b2c-447b-941b-6ce16e297136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_d0b7acd4-50c5-46cf-9646-02682e39ee9d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_436c0dae-9ddd-46ae-bc6c-b6f8caae84a5" xlink:to="loc_dei_WrittenCommunications_d0b7acd4-50c5-46cf-9646-02682e39ee9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_73aadde5-47a3-44c8-9cf2-574dbd7a8593" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_436c0dae-9ddd-46ae-bc6c-b6f8caae84a5" xlink:to="loc_dei_SolicitingMaterial_73aadde5-47a3-44c8-9cf2-574dbd7a8593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_ea3d6a26-de82-405e-a64b-f18ef2b3e9e8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_436c0dae-9ddd-46ae-bc6c-b6f8caae84a5" xlink:to="loc_dei_PreCommencementTenderOffer_ea3d6a26-de82-405e-a64b-f18ef2b3e9e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_8717cdd7-a9d8-46ac-9761-ab99f29dbbec" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_436c0dae-9ddd-46ae-bc6c-b6f8caae84a5" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_8717cdd7-a9d8-46ac-9761-ab99f29dbbec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_61946860-8055-401b-8f5b-427234d71c37" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_436c0dae-9ddd-46ae-bc6c-b6f8caae84a5" xlink:to="loc_dei_EntityEmergingGrowthCompany_61946860-8055-401b-8f5b-427234d71c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_ade35a0c-40df-46c2-bed4-27b212cfb25b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_436c0dae-9ddd-46ae-bc6c-b6f8caae84a5" xlink:to="loc_dei_AmendmentFlag_ade35a0c-40df-46c2-bed4-27b212cfb25b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_dece0541-a0cc-4465-a593-00dc33be074b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_436c0dae-9ddd-46ae-bc6c-b6f8caae84a5" xlink:to="loc_dei_EntityCentralIndexKey_dece0541-a0cc-4465-a593-00dc33be074b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140419921500048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Sep. 29, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 29,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SKYE BIOSCIENCE, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-55136<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">45-0692882<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">11250 El Camino Real<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">410-0266<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001516551<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>skye-20220929_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="skye-20220929.xsd" xlink:type="simple"/>
    <context id="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516551</identifier>
        </entity>
        <period>
            <startDate>2022-09-29</startDate>
            <endDate>2022-09-29</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF80L2ZyYWc6MmYwYzI4MGJlOTM3NDg5OThkMmZjMDg5N2I5NzMwMGQvdGFibGU6YmZhNGRlZjRkMGY4NGQyMzhhMmVkYzJmMWRmYjFmNzYvdGFibGVyYW5nZTpiZmE0ZGVmNGQwZjg0ZDIzOGEyZWRjMmYxZGZiMWY3Nl8wLTEtMS0xLTEwNzQ5OQ_cfed0af1-4eb4-45a3-b364-ab2e86a2a5a5">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF80L2ZyYWc6MmYwYzI4MGJlOTM3NDg5OThkMmZjMDg5N2I5NzMwMGQvdGFibGU6YmZhNGRlZjRkMGY4NGQyMzhhMmVkYzJmMWRmYjFmNzYvdGFibGVyYW5nZTpiZmE0ZGVmNGQwZjg0ZDIzOGEyZWRjMmYxZGZiMWY3Nl8xLTEtMS0xLTEwNzQ5OQ_4326e528-5b74-4c61-893a-00b2a4bce40b">0001516551</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF8xL2ZyYWc6MjVkMTU5MDYwMmUzNDRlZTk2ZGViOTliYWIxYjVjYWQvdGV4dHJlZ2lvbjoyNWQxNTkwNjAyZTM0NGVlOTZkZWI5OWJhYjFiNWNhZF8xMTE2_8b618aa1-7340-4b34-b968-bc6db3389c8d">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF8xL2ZyYWc6MjVkMTU5MDYwMmUzNDRlZTk2ZGViOTliYWIxYjVjYWQvdGV4dHJlZ2lvbjoyNWQxNTkwNjAyZTM0NGVlOTZkZWI5OWJhYjFiNWNhZF8yMzA_5476a762-1fad-4167-a08f-dfdc3576da0a">2022-09-29</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF8xL2ZyYWc6MjVkMTU5MDYwMmUzNDRlZTk2ZGViOTliYWIxYjVjYWQvdGV4dHJlZ2lvbjoyNWQxNTkwNjAyZTM0NGVlOTZkZWI5OWJhYjFiNWNhZF8xMTE0_e4140239-42db-4a00-bd53-3f81a48ca96e">SKYE BIOSCIENCE, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF8xL2ZyYWc6MjVkMTU5MDYwMmUzNDRlZTk2ZGViOTliYWIxYjVjYWQvdGFibGU6NmU4ZDU2NDk1NTU3NDc2YTk4OTE1YzUxYzljNGE1MmIvdGFibGVyYW5nZTo2ZThkNTY0OTU1NTc0NzZhOTg5MTVjNTFjOWM0YTUyYl8wLTAtMS0xLTEwNzQ5OQ_f79c8b3a-3cb9-42b5-bb68-33c9e6680817">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF8xL2ZyYWc6MjVkMTU5MDYwMmUzNDRlZTk2ZGViOTliYWIxYjVjYWQvdGFibGU6NmU4ZDU2NDk1NTU3NDc2YTk4OTE1YzUxYzljNGE1MmIvdGFibGVyYW5nZTo2ZThkNTY0OTU1NTc0NzZhOTg5MTVjNTFjOWM0YTUyYl8wLTItMS0xLTEwNzQ5OQ_a109977f-8bff-4ba6-80ab-7b8ec23c766a">000-55136</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF8xL2ZyYWc6MjVkMTU5MDYwMmUzNDRlZTk2ZGViOTliYWIxYjVjYWQvdGFibGU6NmU4ZDU2NDk1NTU3NDc2YTk4OTE1YzUxYzljNGE1MmIvdGFibGVyYW5nZTo2ZThkNTY0OTU1NTc0NzZhOTg5MTVjNTFjOWM0YTUyYl8wLTQtMS0xLTEwNzQ5OQ_e0baac4e-ba7f-4fdb-87dd-4a52d7a37992">45-0692882</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF8xL2ZyYWc6MjVkMTU5MDYwMmUzNDRlZTk2ZGViOTliYWIxYjVjYWQvdGFibGU6MDIyYzBiNWJiNDhkNDNhYWFhYjMwNTNmNTk2NjY4NzMvdGFibGVyYW5nZTowMjJjMGI1YmI0OGQ0M2FhYWFiMzA1M2Y1OTY2Njg3M18wLTAtMS0xLTEwNzQ5OS90ZXh0cmVnaW9uOjQ3MGFlNTIyMGY5MTRhYTU4NzZjMGY1MzgwMmM5YTJlXzQ_d38e07ff-a5cd-468f-a4f3-8a542679f9fa">11250 El Camino Real</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF8xL2ZyYWc6MjVkMTU5MDYwMmUzNDRlZTk2ZGViOTliYWIxYjVjYWQvdGFibGU6MDIyYzBiNWJiNDhkNDNhYWFhYjMwNTNmNTk2NjY4NzMvdGFibGVyYW5nZTowMjJjMGI1YmI0OGQ0M2FhYWFiMzA1M2Y1OTY2Njg3M18wLTAtMS0xLTEwNzQ5OS90ZXh0cmVnaW9uOjQ3MGFlNTIyMGY5MTRhYTU4NzZjMGY1MzgwMmM5YTJlXzk_6008c927-d77e-485b-8ab8-65d592dc7d1c">Suite 100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF8xL2ZyYWc6MjVkMTU5MDYwMmUzNDRlZTk2ZGViOTliYWIxYjVjYWQvdGFibGU6MDIyYzBiNWJiNDhkNDNhYWFhYjMwNTNmNTk2NjY4NzMvdGFibGVyYW5nZTowMjJjMGI1YmI0OGQ0M2FhYWFiMzA1M2Y1OTY2Njg3M18wLTAtMS0xLTEwNzQ5OS90ZXh0cmVnaW9uOjQ3MGFlNTIyMGY5MTRhYTU4NzZjMGY1MzgwMmM5YTJlXzEz_94f084d5-7e47-43fe-b52f-11f34d0110e9">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF8xL2ZyYWc6MjVkMTU5MDYwMmUzNDRlZTk2ZGViOTliYWIxYjVjYWQvdGFibGU6MDIyYzBiNWJiNDhkNDNhYWFhYjMwNTNmNTk2NjY4NzMvdGFibGVyYW5nZTowMjJjMGI1YmI0OGQ0M2FhYWFiMzA1M2Y1OTY2Njg3M18wLTAtMS0xLTEwNzQ5OS90ZXh0cmVnaW9uOjQ3MGFlNTIyMGY5MTRhYTU4NzZjMGY1MzgwMmM5YTJlXzE3_7daac0ba-c273-403f-85e6-91107bfe8f99">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF8xL2ZyYWc6MjVkMTU5MDYwMmUzNDRlZTk2ZGViOTliYWIxYjVjYWQvdGFibGU6MDIyYzBiNWJiNDhkNDNhYWFhYjMwNTNmNTk2NjY4NzMvdGFibGVyYW5nZTowMjJjMGI1YmI0OGQ0M2FhYWFiMzA1M2Y1OTY2Njg3M18wLTAtMS0xLTEwNzQ5OS90ZXh0cmVnaW9uOjQ3MGFlNTIyMGY5MTRhYTU4NzZjMGY1MzgwMmM5YTJlXzIw_77e80a15-09da-4d27-ac6c-e7a5ec6cc859">92130</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF8xL2ZyYWc6MjVkMTU5MDYwMmUzNDRlZTk2ZGViOTliYWIxYjVjYWQvdGFibGU6NDM2YjIxNTIyMGE1NDcxZDhmNmFmOGNjYjQxYWU1ZTgvdGFibGVyYW5nZTo0MzZiMjE1MjIwYTU0NzFkOGY2YWY4Y2NiNDFhZTVlOF8wLTAtMS0xLTEwNzQ5OS90ZXh0cmVnaW9uOmJlYzY0OTdiYzM2ODRiYTdiMmE1MTE5NzRlZGQzNmM0XzU_ecfe7384-4b53-4971-a3c6-0d210741c93d">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF8xL2ZyYWc6MjVkMTU5MDYwMmUzNDRlZTk2ZGViOTliYWIxYjVjYWQvdGFibGU6NDM2YjIxNTIyMGE1NDcxZDhmNmFmOGNjYjQxYWU1ZTgvdGFibGVyYW5nZTo0MzZiMjE1MjIwYTU0NzFkOGY2YWY4Y2NiNDFhZTVlOF8wLTAtMS0xLTEwNzQ5OS90ZXh0cmVnaW9uOmJlYzY0OTdiYzM2ODRiYTdiMmE1MTE5NzRlZGQzNmM0Xzk_0f3fd77b-e3ce-4888-b84f-576a5f62e203">410-0266</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF8xL2ZyYWc6MjVkMTU5MDYwMmUzNDRlZTk2ZGViOTliYWIxYjVjYWQvdGFibGU6MWFiMDNkZTM1ZWNhNDU4ZWI2YjIyNzA5OTViZGNmZGUvdGFibGVyYW5nZToxYWIwM2RlMzVlY2E0NThlYjZiMjI3MDk5NWJkY2ZkZV8wLTAtMS0xLTEwNzQ5OQ_8028f542-2ebc-4c2c-ac56-497bacb67dd5">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF8xL2ZyYWc6MjVkMTU5MDYwMmUzNDRlZTk2ZGViOTliYWIxYjVjYWQvdGFibGU6MWFiMDNkZTM1ZWNhNDU4ZWI2YjIyNzA5OTViZGNmZGUvdGFibGVyYW5nZToxYWIwM2RlMzVlY2E0NThlYjZiMjI3MDk5NWJkY2ZkZV8xLTAtMS0xLTEwNzQ5OQ_f660bb41-4da9-44d4-98ef-428940ae00a6">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF8xL2ZyYWc6MjVkMTU5MDYwMmUzNDRlZTk2ZGViOTliYWIxYjVjYWQvdGFibGU6MWFiMDNkZTM1ZWNhNDU4ZWI2YjIyNzA5OTViZGNmZGUvdGFibGVyYW5nZToxYWIwM2RlMzVlY2E0NThlYjZiMjI3MDk5NWJkY2ZkZV8yLTAtMS0xLTEwNzQ5OQ_8f62ae68-12e1-41d1-a707-b77890a69ecd">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF8xL2ZyYWc6MjVkMTU5MDYwMmUzNDRlZTk2ZGViOTliYWIxYjVjYWQvdGFibGU6MWFiMDNkZTM1ZWNhNDU4ZWI2YjIyNzA5OTViZGNmZGUvdGFibGVyYW5nZToxYWIwM2RlMzVlY2E0NThlYjZiMjI3MDk5NWJkY2ZkZV8zLTAtMS0xLTEwNzQ5OQ_cb83e66b-72f6-44b0-a15e-a35347420f11">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany
      contextRef="ia49576468c6b4ae095a674505d369dbf_D20220929-20220929"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkNmFlOTZjZTdkZjQzMGU4YTQ3MGNjZTYwNDQ5MjkwL3NlYzphZDZhZTk2Y2U3ZGY0MzBlOGE0NzBjY2U2MDQ0OTI5MF8xL2ZyYWc6MjVkMTU5MDYwMmUzNDRlZTk2ZGViOTliYWIxYjVjYWQvdGV4dHJlZ2lvbjoyNWQxNTkwNjAyZTM0NGVlOTZkZWI5OWJhYjFiNWNhZF8xMTE1_3a98ad2c-5cb8-44ae-8c2c-7c28b1a2de52">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MN!1L>FB'=F'?TT3F'YV/W%GS$W-E,23E*U +KJ[!>/3^^+;O6)671Z:ELG
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MA H#E&^J%977DHHM)]W1ZTSO'R:/6D;KW$JY]_!*MAQSCG^T_ %02P,$%
M  @ V8E#520>FZ*M    ^ $  !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN
M<F5L<[61/0Z#, R%KQ+E #50J4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT8;*>
M+7_OR4Z?:!1W;J"V\R1&:P;*9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2
M*+I!V#-DGNZ9HIP\_D-T==UI?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+B
MRTR6HJ@R&8HJEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#
M!!0    ( -F)0U5ED'F2&0$  ,\#   3    6T-O;G1E;G1?5'EP97-=+GAM
M;*V334[#,!"%KQ)E6R4N+%B@IAM@"UUP 6-/&JO^DV=:TMLS3MI*H!(5A4VL
M>-Z\SYZ7K-Z/$;#HG?78E!U1?!0"50=.8ATB>*ZT(3E)_)JV(DJUDUL0]\OE
M@U#!$WBJ*'N4Z]4SM')OJ7CI>1M-\$V9P&)9/(W"S&I*&:,U2A+7Q<'K'Y3J
M1*BY<]!@9R(N6%"*JX1<^1UPZGL[0$I&0[&1B5ZE8Y7HK4 Z6L!ZVN+*&4/;
M&@4ZJ+WCEAIC JFQ R!GZ]%T,4TFGC",S[O9_,%F"LC*30H1.;$$?\>=(\G=
M560C2&2FKW@ALO7L^T%.6X.^D<WC_0QI-^2!8ECFS_A[QA?_&\[Q$<+NOS^Q
MO-9.&G_FB^$_7G\!4$L! A0#%     @ V8E#50=!36*!    L0   !
M         ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #9B4-5
M?KR[P>X    K @  $0              @ &O    9&]C4')O<',O8V]R92YX
M;6Q02P$"% ,4    " #9B4-5F5R<(Q &  "<)P  $P              @ ',
M 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( -F)0U4SXPL[] ,
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M2P$"% ,4    " #9B4-5)!Z;HJT   #X 0  &@              @ %@$0
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " #9B4-599!Y
MDAD!  #/ P  $P              @ %%$@  6T-O;G1E;G1?5'EP97-=+GAM
7;%!+!08     "0 ) #X"  "/$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>20</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="skye-20220929.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://skyebioscience.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="skye-20220929.htm">skye-20220929.htm</File>
    <File>skye-20220929.xsd</File>
    <File>skye-20220929_lab.xml</File>
    <File>skye-20220929_pre.xml</File>
    <File>skye_093022xvotingresultsp.htm</File>
    <File>skyeletteroffriedmanllptos.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="20">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "skye-20220929.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "skye-20220929.htm"
     ]
    },
    "labelLink": {
     "local": [
      "skye-20220929_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "skye-20220929_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "skye-20220929.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd"
     ]
    }
   },
   "elementCount": 21,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 20,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "skye",
   "nsuri": "http://skyebioscience.com/20220929",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "skye-20220929.htm",
      "contextRef": "ia49576468c6b4ae095a674505d369dbf_D20220929-20220929",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://skyebioscience.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "skye-20220929.htm",
      "contextRef": "ia49576468c6b4ae095a674505d369dbf_D20220929-20220929",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r3": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r4": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001516551-22-000033-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001516551-22-000033-xbrl.zip
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ML"SDH*\)U!7T@3-*-E:+\!2@?+ZG;+K'?+:O48'\5#T4^:M*;(MXBBOJH A
M_!,J6A@A,EW%<F2B>%17OB_^UR;[E;'EE\BTF>%[+I5H#,)F\+":'(@+L.=R
M<0&BH;1RYK-59@=1$K#MK9B&!'-W'M2=G0;365Q<FKY"G"0*A^G#5[Y7JI;_
MW8FG2W%-12>FY$8D/LRP1,(1&2=[![^Z0.YS[P_8=M%2C!\LXF$:]B^OBX$%
M+/2G*.*Q7<":RB[]:2ICFGB7 2\JZ(+6#4F2+,EB^#8.YDH'O7)TQ03GL4$U
MCI;#>3'N.5&XOS0+<[>8&9+J6>$Q1OHTLZPW?FE!W8\Z 4 \M0D>GW>4:3]8
MFH5Z8-),2;"M7]^#HZ<@_QWN?@)WQ+T!#V_8]\1L)C[[<_@;(W7MC+CYV,G6
MQ%S\;T11,&%P:4@F>) SU"&)0$-P>, 'ZD?,_1DFE+6"J6:I27@S%'-0!'Z5
M!SK4;*QPC(.SR\DPK-"'N<&3F-X&";SG!WW2=W'7C;@N%B##QGC9E4=B+^$Y
M2=XJWTO=)Q/?:S8^4Q0F;NEF.V/K7UYB[KV@ _>S'($!%1'>C0DXR,FP!W0V
MSAT[E#O&@^#72FGU7 *CFM*>H!4E63AF9)6P4..$)_Y(A&,4?3XC[B-.NO#[
M]U)1L]D>?E=&/","EH= /A!D3^"RH#^Y\&W*CB R+F[&5/@01(D;8%2\(%3[
M;A'PLH_<. FK :OO8<N]-RAOZ "E!:N</A-5<<+ G65_/XA[!>$D#J@'TQ ^
M?3HK"-3WD>MO,2:;%^Z6>=WN^:;"_E[^%<8$ >2P0#&3/S42N\,>:P4"AL46
M@_Z0)U9&(+90&!(6>GX4K*N#O%NWZA-,SN$&.KMEF)E9VDDF^J-0!3W ]*X[
MPL/RZT6AT5_R<X%'UH9>D JLC$Z:4IH+_>-\1P#3:F\16/C1"Q(LM@,J!5K-
MD08N.M-:_6L0G6P?!YK,4,7B7!\WMP6@4 'B=ZS$#T.RU/PR=?GT5#F?=1.:
MX*!X= \8#/0B3^V=Y;6Y68R", 0]/!(<.M=H.H^B\ HI$JT0M#XF4T8<\\SO
M!.74,MH$*F;V++L?=6IJL&*FN/P)6R0:L#VH;/D&F%&>CB*V;DM2H;<6D^5A
MC"3(4\43,-KY# 5NP"U2ILRX9?%7J3!AHF3H)/2?(;(&)JC'02^W_%;S.&/F
MF HC^*LD[ =O8$617\EU3+,%04$=\-7L4=)G&>V^P-2Q*FE@\.W+;_:#6V;W
M@3X>AEPS78A_ 3^D(TK[7#,AF!/:@09(+:#%4K[0,ZR;G:0- =% "P.T49 5
M"\OH!6%UPR@9QJ#OH#5!L<0L5A?T!W\_<JG'GK-8 3NR@&2+E]B%MUR>YG#]
M :.,HF'H 7&#T'')$'7N!&IHV2,W:(IGMPIR[,UT,"'TC \.V;3W XY8?*I(
MA_P9B\"S:TL2]KM\N!ZJEV'Z%3$%HY6)2)F@GKLK(#\&,P<E0 -$B*0I$20,
MWS&R09(R]4/2:2?^,.X'"?834D9XV3$63@1L?[ERS(B+>4C95C@0$=(+J#O&
M%9PC5D-0%(XF8$[I*ANQ('#1MXP3@P1/C* <Q<WM3N# B+)1E 5.8Z]HC3=%
M\+'%F*0(' _C&/LX9^Q9 ,>8JR%&D?V('=+!\WT1OX3!H1T2^DP+HE8;AND2
MJQ;H ]QF#-@PX9J=. KS8G4K!1^0(\GO?7"Y+T^8CUW(E2/SY"F.R84<>,#4
M8S(0!\&K4UGOS$R+!D$_8!H9N*&'"X&F2LS2M;A/@7.<R*YE>IEC.T<)$499
M=GYV(1.B)XHQ:."AW22,R$RH ",$B$,V_ QR &UX0A+1EAGY/28880U\F"T+
M5_23@ .9.S@!CDG<#CM7*7B (5;%D7"<H>DY06AAH@X87J;3XD#SPUS)$"=N
M:X=<2L]H)0;N*#,\@<:ZE">:D#D%^1/Z,1L70(.AL[%7J(CGT1"RLF'BXQNA
M +THF<+%T,G+>#*_ =<M8YXO$6?M+'-@+/P9A4!)O]!^?"YI.>>%J=*L_,H]
MFPX%DP6%T@6*#*#P&J5I1AP7:>3>=/CD,3^*T1>[-2=KE-'6&^[YS#YAU,_Z
MO@WB=$A"\(( N;<,M:!.T?OGHH>$("'8YA&,R/=D DP*2]PX<'A:6 ^4)?R2
MDB 4,A)F26-!FG5S-YZQZ[@FG&C:2RSY.9,$@L)H$F"<*>8*_QT-KV&Y)OX<
M#W]DTSYCHUSDHTQGWNCCV<U93+%;>-PH9NHXLSA0Q3.B<H8)+%.2S(R7*Y:Y
M\<YY#W@_7#X6,[4%=J%SR&4C0R>(FG0!^V!(3$:>Z:@@:+9>L!6] .0A)!V"
M5L^\ISOC;O5Z49]/;++VQ_Q'1A?S4#%IB$IDF+*(+Y.Q@.E%: O3558-JZ#:
M1D'5S1P6UA4(,/B,.PP>!K91(2>X/C$*<K;8A3SD [R5#E&1$>&?812#<D ?
M<#",4:5-IC:/F28+B*/2G3286;T)A3**S"E4<)@Q@+H/#;=,B&:$CC"3)#M\
MFY2^ZZ]/C[ ?;JK<P%C\(U,&'SL^Z[$4I#!==PW!?9:OA/S$<'T3+YQZ)E2!
MVL*+!IS_CN(810H304>YBL^-=BX(:F0LR)-()QHN/6ZW KU]'()]*&N9)$#Z
M_C@$P2+K2V3#TJ$F_/C =<8L20*2^$]*0A"*,(68#.@07..$1WHG_%WYLYEW
MD]G(41Z/X[;AU)I,>#HG6)*$>TO !LYXMG1%.D$5(F &Y!53F4P@Z-^">\VM
M,! WUUGI=#1?KA.NO8C[SS#(]JAR\P[MJS#,>7I6$,&TA LN85:A,:>OZ?29
M89G'(AT601\.LMC4]* ]BHMD=:+@C['\UAS!5Y6BHC[!+5%/V.UZ%0/62_Q@
MB:]249^_"VYF$_[!LXTLW[%<XJ(5G& =B_^N<?[C]T'(T34)P.[X54B)V0"O
M%65'3I*B!0CJXC''Y!ZZB:Y+Z32_)=^[7X&U5T*%RTT0V5 *JF$7=%M=AP1W
MF%R)2;T@@2=DVN8+X_&UB( 5] H&KP8>M64:CZA@MB$Y/2^8G[.IKN%_*W>Y
M@9\Y[2S*$W'/F05;T7M<\#DN>&))[F] :PPY$1_K7('_ +_CT1LOB"D&;]GN
M':^ R\,I:,!'\=2CV7=YR#/H]:C'"G#QN8)3CJ$N,//GSQ7R#"!)>QC<9/'.
MF1):TU'C67#F0/B%6_+/YM [&^O0*R\%UPH7_R7C"P_""S1!"8D;C\MB="PP
MD-UF1'E43C@;QFX'O%7A+ 3X9]W=RL79V0,_]U%N[KITOW-A=R[L)K@?$Q=V
MY\$^]&!W#NS.@7T)':>  ZM84L&0[9T#^Y.N54$WK8)N2SL/]@G1;!1LPRI(
MNOD(_W5C_0!W8_T =1,W]M#9S#? YA*=CK*=.VQP3EGR@0?VN*P)C5X_<(8)
M.KJH.6YG+?%9<WSA^=-N0.T,\YUAOD%FU<XPWQGF.\-\P^P<-,Q5Q2IH\DOO
MB&P[)F6]8!IFP;*5G6'^E 1;,%6I8+\.P]S;6,-<VR##'&\2RJY( =,X"OII
M?O)S_MSPRK/"WSA[_ 8S\C!7] >/P^9G1&?.I:P\*KK@"4R'.9\.<\:'F1Y(
M3]9S$GXR>+]+2=NY#2\N\'=NP\YMV+D-&X;2Y1I:-=2"89D%W=1V;L//8;)@
MJU9!?_%]D=<B I9CV32E@F)H.Y_A*7T&?9?4LSJIAWC=:!CW'YQ-X_4EP%5(
M$A*/64V*Z163!5;0AM]PA,4'6'XC7G 41W=XK)&7>L.C:#%E10>2(::R!>A4
M, =@\2S/LM,O_'#-BIT)_G NBR@_,_YX#V;^( Y'R/H'<7;Y23M_9JM4T<Z?
MV?DS.W]FPU"ZP@K7E8*J:_#_2T?OMQV3LEI0):M@6R_M&+X6&;!Z&T0M2(K\
M8RX-5FYY(>G%CF686)AUYE#&25DH3TIB;=U!BQ455WC](58C0R!8&3+!.F\A
MQ41]TN\#V;OYD?F%VA0+93WFRIC-]X,7;:4I<3OS=<!LNRCS&F5XEU56J"JK
MO83HCN*>@'?48R83NZ#>C6)XR!*:T*$(V G[2=VZ[2N"4^VSK9K8(UAVCVT(
MG=(^'D\"OR5)XR&O0/VAJ!0GQ5#FZGG-HJF0U1*=UM%-:(I;/]!K?M"(4?3R
MTF /,<X]F<G"S:T:JX,#'AJKP^!,W*6L%AWU\M).V%'2(:R4**O/E;V5M\>"
M.'G;Q0(IDP+<UK+JVZSZ%2N_, J2:2FKK.1=&! G"'E9'?8R 1E*LV)C6->+
M Y4,L:;/#,K@23[/*;!SA#=+<8@C5H,5A@(>67E7=_3P0KX"7DA!,8\OR6!Q
ML,XYXQNLVC-9.AAO4C)M;F &.\G&7KL2U@:5O>+5XY$L;23+DTDELXMIX51>
M$HDMR-I%KC:H,"";(@;#\CF\PC" 6925'[T#:O4SI2AKUB\/ EA64577 ^C'
M[X?*=,I&N&+\[L5,HM5GRFT^]45!*Y#P3->K+L=#F55N&Z"@?Y57(V-=U76J
M?SS#55 K$>#[3V9/<> \+"K'E'F)Z6-L!3"1'):Y6R(HYXS#%P=0Z,1X]V@"
MQCBOJ1OY?I8V%(:#-$J*G138YA/-2TOG246%O*+\@MFQHI;@ZE*];P_(XL'_
MU\0;:+7^KKP!"-ALWO@V@#.\\56R5:#5N]L(G<[,'QUPWCAC+N<Y=SE?.37+
MTCJ!JZ>FY9>8^7$$H AGY!JW]D 6$IXR628I 0\"+.9]%&N>ER589DXL-X^%
MOS^<?Q*\R!VB<['^[>?/'1;X[PFK$XLA#IS#>K<<ZR_@-=A64;)_R&F0K:(M
MK7[\H_;]KMO'=9O)P[Q!3H49+3WN=L3#1XB;W[N3K2@PM?ZE<;*T]_[EJU)M
MP!V03$%=5$_K1\W+\\K%!MTTNUR7_N??LB&MOKV0@1FPU)F2.HVK/?I>RL,5
M'3WW=,]F+G?DVQG_#(,X"S3F>QI3#VHV6HN/95O5"LLNK?2P&G)VJPX+K&=;
M&#PRG@ FLBONIO=K./R@"+-QLP:H[8=]>(=U1X9I)XIA<M[JJ.>6D-&#0L/;
M%-S4[**M_5@$\YO=FD5+MW\\#FD\G1/ZI,)Q!:F\)#";\S?;3_U0;5P<5ROU
MXTI!J-:/BZ_8B5T@AE?@G"Z9T6ZQMFA&KV6Q\$85KR0(#3>-6+9''N+=JM5;
M/Y.>3?H@.>!+*IP-^T$JE#M!&+[2G9ZUN7&E9_J=3++-FFZ=]&AIMZQ;.*,F
M7K%4$HX[ ?7!HP+OBH5K&[R6\?:5W3YP(F\,_W327OC^_P%02P,$%     @
MV8E#5;OT8.5R @  @0<  !$   !S:WEE+3(P,C(P.3(Y+GAS9,U5R6[;,!"]
M^RM8G4MM=AQ)B!V@"0(4<!>D"9);09$CF; DJB05VW]?DK;J)4MCH(<"!DS.
MO#?[4!>7J[I"3R 5%\W$B_S00]!0P7A33KS[NQN<>)?3P>#B \:/GVYGZ%K0
MKH9&HRL)1 -#2Z[GZ(&!6J!"BAH]"+G@3P3CJ2-=B78M>3G7* [C^%@K,\88
M.0O#$6:4CO"(I4.<%J/8GE(V9B&!//E89I2>)TG,(CP<GJ=X5$1CG(SS&(<I
M.TO/SN.$)&-G=*4R1>=0$V02:U2V4A-OKG6;!<%RN?270U_(,HC#, H>O\Q^
M.*BWQ5:\61R@5[FL>OPPL.J<*.CA:K&&/W![R;E0E)OR@4]%'=B$PS1./42T
MECSO--P(65]#0;I*3[RN^=61BA<<F"EZ!;:L!X ]M2:R!/V5U*!:0M_G=CI
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M N^.):P0 [BYVX(#!@XQRFR8-@;3P3N)9X*H5_DL<PM3<PWUKO*)A+EWF2Z
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M.RR&:\1VS$9>#0N]6]/H9D0W%I3/.YT2+87 :P^?L[-(20">Y=1NLF*Z\G(
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M?@7<>'7S_L/Y^TOUYN;FQ^NW?U.WP_/AU4]7;X>W?PR4#%G21+I%;LJ:&G*
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M)7@6>.UX\45WYW>#;A[$_T4C_Y_GQ7\!4$L#!!0    ( -F)0U7:44@-\@(
M *<+   >    <VMY96QE='1E<F]F9G)I961M86YL;'!T;W,N:'1MU59+4]LP
M$+[W5RS)%"[Q*P0(3LBA21AH*64@;::GCFRM8PVVE)&4N.ZO[\9.> R%83AT
M@@\:2]K=;S_M:K7]G=&WX>3GU1A2FV=P]?W3Q?D0&H[G3?>'GC>:C.!L\O4"
M.JX?P$0S:8052K+,\\:7#6BDULY#SRN*PBWV7:5GWN3:6YGJ>)E2!EUN>6/0
M7ZW0B(P//O1W' =&*E[D*"W$&IE%#@LCY RF',TM.,Y::JCFI1:SU$+;;[=A
MJO2M6+)ZWPJ;X6!CI^_5\[Y7@?0CQ<M!GXLE"'[2$+CO=^(D0!['?N<@BJ)C
MSH^.@H[/HT/&NNQ70$YZ)%[K&%MF>-+(A7127.&'1^VY[16"VS0,?/]CX[$<
MTS,2C92U*@]]U^_.+4DD2EKR1)/E^K<&N(.I)39&(A;?SK1:2.[$*E,Z;";5
MUUO/_.KKK52<A.4B*\.]B<C1P"46<*UR)O=:A@+D&-0BJ06-^(-A$)#OU;2H
MR73(3B8D;LC5C&YP;C&/4$/[N%4=^&._[SS^!Z=M9!,O-.4J6622P_AWG#(Y
M0TJI/!?&4 YO.P,:X11NK$:T<.F.W6UW>,I,2I?8*MF"D3MT*8<..L?O.8GN
MDP6UV6T>='OOF<T4(65+!*JX',[IKM=5725P<ULB?!+*Q )EC"TXE[&[V^RV
M@Z.>@5.E<^@Z7X!7E?IIG6A55ZQ 8#-*5BB$3<&F2,1)856=#1C*X41IVA#R
M'KM%,Z,2IH&9E49)OF6D U:!6FA(A,Y=V/@M%43,"+/:K9&4!B[, U1%1O1#
MW)QQA*BLW-$X$\;2&T:O#AT6HP/BC]PARL&A_ZYC_ ,UD=6+K(223M"TMIQ,
M!14*RS(1OX+>;K-#&5F-<*H%<L* BXNK)TR>?9H/"'F]:-5\O?+\8_U64QNE
M_Q7W%P]CNT+^(H\Q,Q;.F%1+U*W*Z&<JO5B^,BHO-EX/M!YV=7-5][1A57O$
M$I_M\S:AOU=AD5'9PCZO\I;6<#W6+6S53 _^ E!+ 0(4 Q0    ( -F)0U6J
MGVT.BAX  #OM   1              "  0    !S:WEE+3(P,C(P.3(Y+FAT
M;5!+ 0(4 Q0    ( -F)0U6[]&#E<@(  ($'   1              "  ;D>
M  !S:WEE+3(P,C(P.3(Y+GAS9%!+ 0(4 Q0    ( -F)0U40N+KM@@D  $!6
M   5              "  5HA  !S:WEE+3(P,C(P.3(Y7VQA8BYX;6Q02P$"
M% ,4    " #9B4-5]7=#T4$&   &+0  %0              @ $/*P  <VMY
M92TR,#(R,#DR.5]P<F4N>&UL4$L! A0#%     @ V8E#5=@+>@J"#@  *C0
M !X              ( !@S$  '-K>65?,#DS,#(R>'9O=&EN9W)E<W5L='-P
M+FAT;5!+ 0(4 Q0    ( -F)0U7:44@-\@(  *<+   >              "
M 4%   !S:WEE;&5T=&5R;V9F<FEE9&UA;FQL<'1O<RYH=&U02P4&      8
,!@"< 0  ;T,

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
